Zealand Pharma A/S (ZLDPF)
OTCMKTS
· Delayed Price · Currency is USD
72.00
+7.50 (11.63%)
May 1, 2025, 9:35 AM EDT
Zealand Pharma Revenue
In the year 2024, Zealand Pharma had annual revenue of 62.69M DKK, down -81.71%. Zealand Pharma had revenue of 9.06M in the quarter ending December 31, 2024, a decrease of -61.02%.
Revenue
62.69M DKK
Revenue Growth
-81.71%
P/S Ratio
569.04
Revenue / Employee
187.14K DKK
Employees
335
Market Cap
4.95B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62.69M | -280.10M | -81.71% |
Dec 31, 2023 | 342.79M | 238.80M | 229.65% |
Dec 31, 2022 | 103.99M | -4.56M | -4.20% |
Dec 31, 2021 | 108.55M | -83.46M | -43.47% |
Dec 31, 2020 | 192.00M | 150.67M | 364.52% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Zealand Pharma News
- 4 days ago - Zealand Pharma says obesity drug deal with Roche will help it stay independent - Financial Times
- 6 days ago - Zealand Pharma gains as trial for Roche-partnered obesity drug starts - Seeking Alpha
- 7 days ago - Zealand Pharma begins mid-stage trial for obesity drug candidate in people with type 2 diabetes - Reuters
- 7 days ago - Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes - GlobeNewsWire
- 8 days ago - Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery - GlobeNewsWire
- 10 days ago - Zealand Pharma (ZLDPF) Launches 2025 Incentive Program | ZLDPF Stock News - GuruFocus
- 11 days ago - Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons - GlobeNewsWire
- 11 days ago - Zealand Pharma launches long-term incentive programs for Zealand Pharma's Board of Directors, Corporate Management and employees for 2025 - GlobeNewsWire